Table 1. Clinicopathological features of the bladder cancer (BC) patients and normal controls examined in the tissue mRNA expression study.
| Variable | No. of BC patients | No. of controls |
|---|---|---|
| No. of patients | 73 | 7 |
| Age (yr) | 65.16±13.94 | 50.14±10.43 |
| Sex | ||
| Male | 58 (79.5) | 1 (14.3) |
| Female | 15 (20.5) | 6 (85.7) |
| Grade | ||
| G1 | 17 (23.3) | - |
| G2 | 34 (46.6) | - |
| G3 | 19 (26.0) | - |
| Unknown | 3 (4.1) | - |
| T stage | ||
| NMIBC | 47 (64.4) | - |
| Ta | 16 (21.9) | - |
| T1 | 31 (42.5) | - |
| MIBC | 26 (35.6) | - |
| T2 | 6 (8.2) | - |
| T3 | 8 (11.0) | - |
| T4/any T N+/M+ | 12 (16.4) | - |
| N stage | ||
| N0 | 64 (87.7) | - |
| N (1–3) | 9 (12.3) | - |
| M stage | ||
| M0 | 66 (90.4) | - |
| M1 | 7 (9.6) | - |
Values are presented as mean±standard deviation or number (%).
NMIBC, nonmuscle invasive bladder cancer; MIBC, muscle invasive bladder cancer.